Search Results 1511-1520 of 16038 for Epilepsy (Partial Onset)
... Epilepsy Foundation and National Alliance for the Mentally Ill, among others. She joined Mayo Clinic Health System in 2005 and Mayo Clinic in 2015 ...
surgery procedures, symptomatic inflammatory bowel disease, or partial or complete bowel obstruction (for those receiving CAPOX in Part C). 3. Prior therapy ...
Allergy tests. Skin tests can show if allergies are causing ongoing inflammation. With a skin prick test, tiny drops of allergy-causing agents are pricked into ...
... duration than appropriate for a placebo or sham control. Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis Rochester, MN. The ...
Subject has a history of seizures within 12 months of Cycle 1 Day-2 or diagnosed neurological condition placing subject at the increased risk of seizures.
About this study. The primary purpose of this study is to collect long-term (2-month duration) data with the ADI CHF Device on patients at home to ...
Additional recommendations may come in January 2023. Scheduling appointments. Beginning immediately, those who wish to schedule an appointment can use Patient ...
... epilepsy. 2. Age 18 – 65. Exclusion Criteria: 1. Patients who have cognitive impairments that would limit their ability toparticipate in the memory testing. 2 ...
The team also is determining optimal appointment duration for various patient groups according to patient characteristics and conditions. An example ...
Jamie Van Gompel, a neurosurgeon at Mayo Clinic, explains how deep brain stimulation is being used to control seizures for some epilepsy patients. And Dr ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.